AHE-MB (Advances in Hematology) 2026 is an educational event designed for healthcare professionals involved in the care of patients with hematologic malignancies. This inaugural meeting will provide practical, evidence-based updates on rapidly evolving areas of malignant hematology, including chronic lymphocytic leukemia, multiple myeloma, aggressive lymphomas, and bispecific antibodies. Through expert-led sessions, participants will explore emerging evidence and evolving treatment strategies that can be applied to optimize patient care in clinical practice.

Date: September 26, 2026
Time: 8:15 – 12:00
Location: Victoria Inn Hotel & Conference Centre
Virtual attendance also available!

Learning Objectives

• Review current standards of care for the management of common hematologic malignancies, including aggressive lymphomas, chronic lymphocytic leukemia, and multiple myeloma.
• Evaluate emerging evidence supporting the use of novel therapies, including bispecific antibodies, and their integration into clinical practice.
• Apply evolving evidence and treatment strategies to optimize the care of patients with hematologic malignancies. 

Register now: AHE-MB (Advances in Hematology) 2026 – Continuing Professional Development – Rady Faculty of Health Sciences